Josep Llorens - Jan 23, 2023 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role
EVP, Global Manufacturing
Signature
/s/ Thomas V. Powers, attorney-in-fact for Mr. Llorens
Stock symbol
HAE
Transactions as of
Jan 23, 2023
Transactions value $
-$79,931
Form type
4
Date filed
1/25/2023, 03:28 PM
Previous filing
Sep 7, 2022
Next filing
May 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Options Exercise $135K +2.39K +13.87% $56.57 19.6K Jan 23, 2023 Direct F1, F2
transaction HAE Common Stock Sale -$215K -2.39K -12.18% $90.00 17.2K Jan 23, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HAE Non-qualified Stock Option (Right to Buy) Options Exercise $0 -2.39K -25% $0.00 7.17K Jan 23, 2023 Common Stock 2.39K $56.57 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction pursuant to an existing 10b5-1 trading plan.
F2 This number includes unvested restricted stock units previously reported.
F3 Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.